Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Upplands Vasby – page 32

847 clinical trials in Upplands Vasby, Sweden. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Upplands Vasby at a glance
847
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

847 trials in Upplands Vasby

Open in trial search

End stage renal disease+1

Not yet recruiting

Safety and efficacy of locally administered APAC, heparin sodium and sodium chloride to promote arteriovenous fistula maturation in patients with end‑stage kidney disease

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Heparin Sodium
  • Sponsor:Aplagon Oy

Cardiovascular disorder+3

Not yet recruiting

Effect of dapagliflozin on cardiovascular events in patients receiving chronic dialysis

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Karolinska University Hospital

Pulmonary embolism

Not yet recruiting

Reduced-dose versus full-dose alteplase for high-risk acute pulmonary embolism patients: a randomized multicenter trial

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Alteplase
  • Sponsor:University Of Gothenburg
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:AZD0120
  • Sponsor:AstraZeneca AB

Overweight+1

Not yet recruiting

Effect of bupropion hydrochloride and mushroom supplement on body weight in overweight adults: a 52‑week randomized trial

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Bupropion Hydrochloride
  • Sponsor:Uppsala University

Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Norwegian University Of Science And Technolology

Dementia Alzheimer's type

Not yet recruiting

A Phase 2 Study of TML-6 in Adults with Early Alzheimer’s Disease to Evaluate Safety, Tolerability, and Efficacy

Investigational
Countries:SwedenSweden
  • Participants:65+ years
  • Substances:TML-6
  • Sponsor:Merry Life Biomedical Co. Ltd.

Obesity

Not yet recruiting

Safety, tolerability and efficacy of XEN-D0501 in adults with obesity

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:XEN-D0501
  • Sponsor:Pila Pharma AB

Phase II Study of Lutetium (177Lu) Zadavotide Guraxetan Radioligand Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Lutetium (177LU) zadavotide guraxetan
  • Sponsor:Region Uppsala

Sedative therapy

Not yet recruiting

Patient‑controlled propofol versus alfentanil and midazolam sedation for adenoma patients undergoing diagnostic and therapeutic colonoscopy: a satisfaction study

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Alfentanil
  • Sponsor:Karolinska Institutet

Malignant melanoma stage IV+1

Not yet recruiting

Phase Ib/II study of momelotinib with nivolumab or pembrolizumab in unresectable stage III/IV cutaneous melanoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Momelotinib
  • Sponsor:Karolinska University Hospital

Adrenogenital syndrome

Not yet recruiting

Study of Crinecerfont in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Androgen Levels

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Crinecerfont
  • Sponsor:Neurocrine Biosciences Inc.

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Upplands Vasby

What the registry says about research in the country

01 Neurology

Clinical research focusing on migraine treatment, evaluating new therapeutic approaches for acute attacks. These trials aim to assess the effectiveness of novel medications in managing migraine symptoms and improving patient outcomes.

  • Acute migraine treatment
  • Pain management
  • Neurological disorders

Studies include double-blind, placebo-controlled methodologies to ensure reliable results.

02 Infectious Diseases

Ongoing research into Herpes Zoster prevention, with studies examining long-term vaccine efficacy and immune response in older adults. These trials focus on protecting vulnerable populations against shingles.

  • Vaccine development
  • Immune response
  • Preventive medicine

Research emphasizes long-term safety monitoring and effectiveness evaluation.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.